Shares of Guardant Health rose to $106.97 during today's afternoon trading session. Despite the 6.7% change, the Large-Cap Medical Specialities company still trades 8.05% above its average analyst target price of $99.0. So there may be further downside for the Medical Specialities stock. Guardant Health has target prices ranging from $60.0 to $120.0 per share, and its average rating is buy.
Guardant Health has an average level of shares sold short, at 7.0% of its total share float. The stock's short ratio (also called days to cover) is 3.31. The company's insiders own 4.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Institutional investors own 97.0% of Guardant Health's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Guardant Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-09-30 | Vanguard Group Inc | 9% | 11,908,829 | $1,273,915,981 |
| 2025-09-30 | Blackrock Inc. | 9% | 11,429,315 | $1,222,621,219 |
| 2025-09-30 | BAILLIE GIFFORD & CO | 4% | 5,127,692 | $548,521,503 |
| 2025-09-30 | Invesco Ltd. | 4% | 4,929,543 | $527,325,030 |
| 2025-09-30 | Capital International Investors | 4% | 4,689,241 | $501,619,349 |
| 2025-09-30 | Price (T.Rowe) Associates Inc | 3% | 4,221,637 | $451,598,628 |
| 2025-09-30 | Deep Track Capital, Lp | 3% | 4,154,086 | $444,372,536 |
| 2025-09-30 | Eventide Asset Management LLC | 3% | 3,321,338 | $355,291,486 |
| 2025-09-30 | Wellington Management Group, LLP | 3% | 3,249,085 | $347,562,410 |
| 2025-09-30 | Geode Capital Management, LLC | 2% | 2,936,656 | $314,141,131 |
